Corcept Therapeutics Inc. | Mutual Funds
Mutual Funds that own Corcept Therapeutics Inc.
Federated Kaufmann Fund
11,000,000
9.48%
-756,795
2.44%
06/29/2018
iShares Core S&P Small Cap ETF
5,006,016
4.3%
0
0.16%
09/06/2018
Vanguard Small Cap Index Fund
2,612,028
2.25%
35,489
0.04%
07/31/2018
Vanguard Total Stock Market Index Fund
2,587,898
2.23%
22,590
0.01%
07/31/2018
iShares Russell 2000 ETF
2,044,390
1.76%
-1,092
0.06%
09/06/2018
iShares S&P Small Cap 600 Growth ETF
1,640,612
1.41%
2,354
0.34%
09/06/2018
Vanguard Small Cap Growth Index Fund
1,488,770
1.28%
20,161
0.09%
07/31/2018
Vanguard Extended Market Index Fund
1,263,036
1.09%
11,500
0.03%
07/31/2018
PowerShares S&P Small Cap Health Care Portfolio
1,096,484
0.95%
69,718
1.32%
09/05/2018
iShares Russell 2000 Growth ETF
948,198
0.82%
0
0.12%
09/06/2018
| Address |
149 Commonwealth Drive
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.corcept.com |
| Updated |
07/08/2019 |
| Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. |
